Mach5 Therapeutics, Inc. — Form D
Mach5 Therapeutics, Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-03. The offering totals $3.0M, of which $2.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-04-03
- Form: D
- Accession: 0002018014-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.7M
- Remaining: $325K
- Investors: 6
- Date of first sale: 2024-03-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-509501
Issuer
- Name: Mach5 Therapeutics, Inc.
- CIK: 0002018014
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 650 PONCE DE LEON AVE, ATLANTA, GA, 30308
- Phone: 404-487-8769
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Justin J DiMartino | Director | Atlanta, GA |
| Justin J DiMartino | Executive Officer | Atlanta, GA |
| Justin J DiMartino | Promoter | Atlanta, GA |
| Patrick J Crutcher | Director | Atlanta, GA |
| Patrick J Crutcher | Executive Officer | Atlanta, GA |
| Patrick J Crutcher | Promoter | Atlanta, GA |
Other filings by this issuer (2)
More